BRIEF-Organon To Acquire Dermavant Including Its Innovative Dermatologic Therapy, Vtama® (Tapinarof) Cream, 1%

Reuters
18 Sep 2024

Sept 18 (Reuters) - Organon & Co :

* ORGANON TO ACQUIRE DERMAVANT INCLUDING ITS INNOVATIVE DERMATOLOGIC THERAPY, VTAMA® (TAPINAROF) CREAM, 1%

* ORGANON & CO - DEAL VALUED AT UP TO $1.2 BILLION

* ORGANON & CO: DEAL TO BE MODESTLY DILUTIVE TO ADJUSTED EBITDA IN 2025, TURNING ACCRETIVE IN 2026

* ORGANON & CO-FDA REVIEWING SNDA FOR VTAMA CREAM AS POTENTIAL TREATMENT FOR AD IN ADULTS & CHILDREN 2 YRS OF AGE &OLDER,WITH PDUFA ACTION SEES IN Q4

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10